Rodolfo Galindo, MD - Program Co-Chair
University of Miami
Laya Ekhlaspour, MD – Program Co-Chair
University of California, San Francisco
Janet B. McGill, MD
Washington University School of Medicine
Faisal Malik, MD, MSHS
University of Washington
Luisa A. Duran, MD
John Muir Health
Irl B. Hirsch, MD, MACP
University of Washington School of Medicine
Persis Commissariat, PhD, CDCES
Harvard Medical School
Anne Peters, MD
University of Southern California
Camille E. Powe, MD
Harvard Medical School
Elizabeth R. Seaquist, MD
University of Minnesota Medical School
Robert Eckel, MD
University of Colorado Anschutz Medical Campus
Mark A. Atkinson, PhD
University of Florida, Departments of Pathology and Pediatrics
Ileana Vargas, MD, MS
Columbia University Medical Center
Lorena Alarcon-Casas Wright, MD, FACE
University of Washington School of Medicine
Marconi Abreu, MD
University of Texas, Southwestern
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.
The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
Rodolfo J. Galindo, MD was supported in part by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH). He has received research grants/support from Novo Nordisk, Eli Lilly, Boehringer and Dexcom, and consulting/advisory/honoraria from Abbott Diabetes, Boehringer, Dexcom, Eli Lilly, Novo Nordisk.
Laya Ekhlaspour, MD receives salary support from NIDDK. She has served on the Advisory Board of Abbot t, Diabetes Center Berne, Sequel, and Medtronic; and has consulted for Jaeb, and Tandem Diabetes Care; and has received honorarium from Medtronic, Tandem Diabetes Care, and Insulet.
Janet B. McGill, MD, MA, FACE has served as a consultant for Boehringer Ingelheim and Mannkind; and received grant funding from Novo Nordisk and JDRF.
Lorena Alarcon-Casas Wright, MD, FACE serves on the Advisory Board for Genentech.
Anne Peters, MD serves on the Advisory Board for Medscape and Vertex, and receives research support from Insulet, Abbott Diabetes Care, and Zucara.
Camille E. Powe, MD serves as consultant for Mediflix, Inc; is a Pregnancy and Reproductive Health Interest Group Chair and Associate Editor for the American Diabetes Association; a journal section editor for Current Diabetes Reports; and receives grants from NIH/NIDDK, NIH/NICHD, K23, U01 and R01.
Elizabeth R. Seaquist, MD has served on the Eli Lilly Global Diabetes Care Advisory Board, the NIDDK Advisory Committee and the External Advisory Committee for the University of Michigan Caswell Diabetes Center; has been a consultant for Zucara Therapeutics; is a member of the International Hypoglycemia Study Group; and received grants from the NIH and JDRF.
Ileana Vargas, MD, MS has served as an Affiliate Board Member for the American College of Culinary Medicine.
Robert Eckel, MD has served as a Scientific Advisor for Regeneron Pharmaceuticals, Novo Nordisk, and Amgen; and has served on the Advisory Boards for 89bio, Ionis, Precision BioSciences and UpToDate.
Irl B. Hirsch, MD has served as a consultant for Abbott Laboratories, Lifescan, Embecta, and GWave; and received grant funding from Dexcom and Insulet Corporation.
Mark Atkinson, PhD has served as a board member for Diamyd Medical; and has been a medical advisor for Quell Rx, Sanofi, Provention Bio, Endsulin, Vertex Pharmaceuticals and Novo Nordisk
The following faculty reported no relevant financial relationships: Faisal S. Malik, MD, MSHS; Luisa A. Duran, MD; Persis Commissariat, PhD, CDCES; Marconi Abreu, MD
ACKNOWLDEGEMENT OF COMMERCIAL SUPPORT
This educational activity is supported by educational grant from Abbott Diabetes Care, Cequr, Dexcom, Insulet, JDRF, Lilly USA, Mannkind, Medtronic, Novo Nordisk, and Vertex.